National Accounts Director, Market Access (Hybrid)

Careerwebsite; Massachusetts; Hybrid; USD 261,000 - 319,000; Full time

Job summary

Disc Medicine seeks a National Account Director to lead access strategies across national/regional payers, PBMs, and GPOs, ensuring patient access to our therapies. Reporting to the VP, Market Access, you will educate cross-functional teams, manage payer relationships, and drive strategic plans with senior executives, while traveling up to 60% as required in a field-based role.

This role demands strategic insight, collaboration, and a proven track record launching rare therapies with payer and

Qualifications

• Bachelor's degree required or equivalent.
• 15+ years' experience in Market Access in biopharmaceutical/pharmaceutical industry.
• 5+ years' experience in an account management role launching rare therapies with payer/PBM customers.
• Experience negotiating with payers/PBMs.
• Expert knowledge of U.S. managed markets including commercial and government payers.

Responsibilities

• Develop and implement national/account access strategies for commercial, government payers, PBMs and GPOs.
• Lead engagements with senior payor executives to secure favorable coverage policies.
• Coordinate across regions and teams to ensure payer access across products and programs.
• Educate cross-functional teams on payer policies and market dynamics.
• Travel frequently to align strategies with field teams and customers.

Skills

Collaboration

Verbal communication

Written communication

Clinical knowledge

Problem solving

Education

Bachelor's degree in relevant field

Job description

Disc Medicine seeks a National Account Director to lead access strategies across national/regional payers, PBMs, and GPOs, ensuring patient access to our therapies. Reporting to the VP, Market Access, you will educate cross-functional teams, manage payer relationships, and drive strategic plans with senior executives, while traveling up to 60% as required in a field-based role.

This role demands strategic insight, collaboration, and a proven track record launching rare therapies with payer and